The Ritedose Corporation
The Ritedose Corporation
HOME
ABOUT US
MANUFACTURING
QUALITY
DEVELOPMENT
503B CONTACT US
News
CONTACT
Slider/Gallery Format
The Ritedose Corporation
>
Gallery
>
Slider
Slider/Gallery Format
July 20, 2015
Continue reading
Recent Posts
Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.
Ritedose Launches Two New Single-Dose Syringe Products Amid National Drug Shortage:
Bupivacaine Hydrocholoride 0.25% (2.5 mg/mL) and Bupivacaine Hydrocholoride 0.5% (5 mg/mL)
Ritedose Launches Critical Single-Dose Syringe Product Amid National Drug Shortage:
Lidocaine Hydrochloride 1% 100 mg/10 mL
Ritedose Reaches Milestone with Asset Purchase
Becomes largest generic drug maker of its kind
Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals:
Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL)
Recent Comments
Archives
January 2023
November 2022
October 2022
February 2022
January 2022
December 2021
September 2021
August 2021
May 2021
April 2021
March 2021
November 2020
August 2020
March 2020
Categories
In the News
Press Releases
Uncategorized
Meta
Log in
Entries feed
Comments feed
WordPress.org
Recent News
Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.
Posted on 30th January, 2023
Ritedose Launches Two New Single-Dose Syringe Products Amid National Drug Shortage:
Bupivacaine Hydrocholoride 0.25% (2.5 mg/mL) and Bupivacaine Hydrocholoride 0.5% (5 mg/mL)
Posted on 17th November, 2022
Ritedose Launches Critical Single-Dose Syringe Product Amid National Drug Shortage:
Lidocaine Hydrochloride 1% 100 mg/10 mL
Posted on 17th October, 2022
Post Categories
In the News
(12)
Press Releases
(10)
Uncategorized
(11)
Search Posts
×
Your ticket for the: Slider/Gallery Format
Title
Slider/Gallery Format
USD
-
-
-
Recent Comments